NEW YORK (GenomeWeb) – The US Food and Drug Administration announced the first specific details of how it plans to regulate genome-edited food and therapeutic products.

In an FDA Voice blog post attributed to outgoing Commissioner Robert Califf and Senior Policy Advisor Ritu Nalubola, the agency said it will take a product-specific, science- and risk-based approach to regulation.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.